Opendata, web and dolomites

NEOCANTAL

New Oleocanthal-based functional ingredients with anti-inflamatory properties obtained from olive pomace valorisation

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 NEOCANTAL project word cloud

Explore the words cloud of the NEOCANTAL project. It provides you a very rough idea of what is the project "NEOCANTAL" about.

food    anti    natural    follow    trial    recognised    cosmetics    material    varieties    deepen    encapsulated    industries    industry    iacute    turn    cumulative    ingenier    70    turnover    pursposes    cruz    launching    treatment    customers    healthy    dramatically    economy    exist    nonsteroidal    sole    phenols    mediterranean    diseases    wellbeing    santa    forms    opportunity    olive    diverse    neocantal    obtain    industrial    op    ingredients    17    pure    patients    engineering    diet    people    evoo    economic    drugs    feasibility    patent    health    virgin    harmful    producers    last    nutrition    mitigate    tackle    pain    inflammatory    extracts    raw    cid    extra    powder    relationship    chronic    decades    pomace    circular    times    commercial    ibuprofen    oil    concentration    compounds    oleocanthal    environmentally    spanish    care    pollutant    liquid    differentiate    stable    agro    specialised    demonstrated    intake    agronomic    functional    pharma    firm    15m    viability    identification    points    packaging    valuable    clinical    added   

Project "NEOCANTAL" data sheet

The following table provides information about the project.

Coordinator
SANTA CRUZ INGENIERIA SL 

Organization address
address: AVDA.EDUARDO DATO NUM 45 ESC 1 PLANTA B
city: SEVILLA
postcode: 41018
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Spain [ES]
 Project website https://www.santacruzingenieria.com/proyectos-de-id/neocantal/
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.3. (PRIORITY 'Societal challenges)
2. H2020-EU.2.3. (INDUSTRIAL LEADERSHIP - Innovation In SMEs)
3. H2020-EU.2.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies)
 Code Call H2020-SMEInst-2018-2020-1
 Funding Scheme SME-1
 Starting year 2019
 Duration (year-month-day) from 2019-02-01   to  2019-07-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    SANTA CRUZ INGENIERIA SL ES (SEVILLA) coordinator 50˙000.00

Map

 Project objective

Chronic inflammatory diseases (CID) have dramatically risen in the last decades. Current sole treatment for patients is the long-term intake of nonsteroidal anti-inflammatory drugs with associated harmful side effects, such as ibuprofen, to mitigate their pain. Research has demonstrated that there exist a strong relationship between nutrition and chronic diseases. This way, the extra virgin olive oil’s (EVOO) health effects have been assessed through diverse studies focusing on the Mediterranean diet. Researchers have recognised natural anti-inflammatory properties to oleocanthal, one of the phenols compounds present in the EVOO. Concentration of oleocanthal is 100 times higher in the olive pomace (OP), a highly pollutant by-product from the olive oil industry. Santa Cruz Ingeniería is an agro-industrial engineering firm specialised in agronomic management and R&D. During last years, we have focused on the identification of oleocanthal-rich olive varieties and on the process to obtain stable oleocanthal extracts (Spanish patent application under study). NEOCANTAL is a great Circular Economy opportunity (cumulative turnover of €17.15M three years after its launching) to turn the environmentally harmful and low-cost OP into a valuable raw material for new oleocanthal-rich (60-70% pure) functional ingredients with anti-inflammatory pursposes. It will be produced in three different forms to be added to a wide range of food products: OP powder, liquid and encapsulated oleocanthal. Our target customers are food producers willing to differentiate their products as functional, while our end-users are CID’s patients, but also people who care of their wellbeing or follow healthy trends. In the future, we will address the cosmetics, food packaging and pharma industries. This Feasibility Study’s goal is to deepen in those key points to assess the economic, technical and commercial viability of NEOCANTAL (including a clinical trial) to tackle this challenge for us to scale-up.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "NEOCANTAL" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "NEOCANTAL" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.;H2020-EU.2.3.;H2020-EU.2.1.)

MCBD (2019)

MCBD (MULTI-CORE BIOPSY DEVICE) INNOVATIVE BIOPSY TECHNOLOGY FOR THE NEW ERA OF TARGETED MEDICINE

Read More  

CyreenApplication (2019)

Connecting Ad-Impressions with Purchase. The new advanced Advertisement at the point of sales.

Read More  

Genetta (2019)

Pole climbing solution to improve safety at work and to prevent fatal accidents in industrial climbing

Read More